IL1B and glioblastoma: Through interaction of S100B with receptor for advanced glycation end products (RAGE) on macrophages, GBM cells induce the STAT3 pathway in TAMs and inhibit the production of IL-1β, TNF-α, and other pro-inflammatory cytokines by these cells (51).